GlassScriptPhysician profile
Hoda H Maarouf
NPI 1861694614
$14,588.31
in general payments reported to CMS, 2019-2025
44 companies · $923 in 2025
The $923 reported for 2025 was more than what 90% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $515 · 2020: $697 · 2021: $1,365 · 2022: $9,181 · 2023: $1,003 · 2024: $904 · 2025: $923.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,723 · Education: $107.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,723.29 |
| Education | $107.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,125.36 | 2022 | |
| Abbvie INC. | $1,452.34 | 2019-2025 | |
| Mayne Pharma Commercial LLC | $574.16 | 2021-2025 | |
| Astellas Pharma US INC | $514.50 | 2019-2025 | Veozah, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $417.06 | 2019-2025 | |
| Therapeuticsmd, INC. | $320.81 | 2019-2021 | |
| Millicent US INC | $320.66 | 2020-2025 | Intrarosa, Femring, Femlyv |
| Agile Therapeutics, INC. | $257.59 | 2021-2024 | Twirla |
| Exeltis, USA INC. | $253.75 | 2019-2025 | Tyblume, Slynd |
| Sage Therapeutics, LLC | $203.01 | 2021-2025 | Zurzuvae |
| Avion Pharmaceuticals | $202.65 | 2019-2023 | Balcoltra |
| Pfizer INC. | $175.09 | 2021-2025 | |
| Organon LLC | $173.01 | 2021-2025 | Nexplanon |
| Lilly USA, LLC | $150.68 | 2020-2024 | Zepbound, Jardiance |
| Evofem Biosciences, INC. | $146.05 | 2021-2022 |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $139.75 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $139.64 | 2024-2025 | Myfembree, Gemtesa |
| Merck Sharp & Dohme LLC | $135.31 | 2019-2022 | |
| Hologic Sales and Service, LLC | $103.78 | 2019-2025 | Thinprep 2000 Processor, Aptima, Coolseal Generator |
| Exact Sciences Corporation | $103.08 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Coopersurgical, INC. | $96.71 | 2024-2025 | Endosee, Paragard T 380a |
| Myovant Sciences INC. | $71.92 | 2021-2022 | |
| Roche Diagnostics Corporation | $48.93 | 2020-2021 | |
| Novo Nordisk INC | $43.94 | 2023-2025 | Wegovy |
| Innovation Technologies INC | $38.93 | 2022 | |
| Lupin INC. | $35.24 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $32.00 | 2022 | |
| Dermira, INC. | $27.38 | 2020 | |
| Mylan Pharmaceuticals INC. | $26.92 | 2021 | |
| Amag Pharmaceuticals, INC. | $26.04 | 2019 | |
| Scynexis, INC. | $24.68 | 2022 | |
| Smith+Nephew, INC. | $21.06 | 2025 | Pico |
| Baxter Healthcare | $20.48 | 2025 | Perclot |
| Pharmacosmos Therapeutics INC. | $20.25 | 2025 | Monoferric |
| Hologic INC | $19.75 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $16.78 | 2022 | |
| Davol INC. | $15.95 | 2023 | Channel Drain |
| Amgen INC. | $15.32 | 2019 | |
| Mission Pharmacal Company | $14.81 | 2021 | |
| Medtronic, INC. | $14.64 | 2022 | |
| Convatec INC. | $12.92 | 2022 | |
| Ibsa Pharma INC. | $12.12 | 2020 | |
| Mallinckrodt Hospital Products INC. | $11.63 | 2020 | |
| Channel Medsystems, INC. | $11.63 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hoda Maarouf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.